{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T13:15:48Z","timestamp":1776777348369,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["2018R1A5A2020732"],"award-info":[{"award-number":["2018R1A5A2020732"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI17C0501"],"award-info":[{"award-number":["HI17C0501"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.intimp.2018.12.020","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T01:13:00Z","timestamp":1544577180000},"page":"152-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Direct potentiation of NK cell cytotoxicity by 8-azaguanine with potential antineoplastic activity"],"prefix":"10.1016","volume":"67","author":[{"given":"Nayoung","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Wan","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ah Young","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Seon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye-Ran","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sojung","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inki","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hun Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2018.12.020_bb0005","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(1950)3:5<896::AID-CNCR2820030518>3.0.CO;2-P","article-title":"The effect of azaguanine on mitosis in normal and neoplastic tissues","volume":"3","author":"Shapiro","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.intimp.2018.12.020_bb0010","first-page":"178","article-title":"The effect of 8-azaguanine on the growth of carcinoma, sarcoma, osteogenic sarcoma, lymphosarcoma and melanoma in animals","volume":"10","author":"Sugiura","year":"1950","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0015","first-page":"283","article-title":"8-Azaguanine (NSC-749). I. Preclinical toxicity studies and a preliminary report on intrathecal perfusion therapy for patients","volume":"50","author":"Rubin","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.intimp.2018.12.020_bb0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1182\/blood.V10.5.482.482","article-title":"Response of patients with leukemia to 8-azaguanine","volume":"10","author":"Colsky","year":"1955","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2018.12.020_bb0025","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3181\/00379727-78-19118","article-title":"Resistance in leukemic cells to a guanine analog, 8-azaguanine","volume":"78","author":"Law","year":"1951","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.intimp.2018.12.020_bb0030","first-page":"856","article-title":"A mechanism of resistance to 8-azaguanine. II. Studies with experimental neoplasms","volume":"19","author":"Brockman","year":"1959","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/1535-7163.MCT-15-0527","article-title":"Identification of selective lead compounds for treatment of high-ploidy breast cancer","volume":"15","author":"Choudhary","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.intimp.2018.12.020_bb0040","doi-asserted-by":"crossref","first-page":"9471","DOI":"10.1093\/nar\/gkt727","article-title":"Characterization of novel inhibitors of HIV-1 replication that function via alteration of viral RNA processing and rev function","volume":"41","author":"Wong","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0045","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02236-17","article-title":"Compounds with potential activity against Mycobacterium tuberculosis","volume":"62","author":"Sao Emani","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.intimp.2018.12.020_bb0050","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/1087057112436557","article-title":"Agents that stabilize mutated von Hippel-Lindau (VHL) protein: results of a high-throughput screen to identify compounds that modulate VHL proteostasis","volume":"17","author":"Ding","year":"2012","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.intimp.2018.12.020_bb0055","first-page":"388","article-title":"Novel immune modulators used in hematology: impact on NK cells","volume":"3","author":"Krieg","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2018.12.020_bb0060","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2141.2004.05286.x","article-title":"Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application","volume":"128","author":"Hayashi","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2018.12.020_bb0065","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2007.06841.x","article-title":"Immunomodulatory drugs stimulate natural killer-cell function, alter cytokine production by dendritic cells, and inhibit angiogenesis enhancing the anti-tumour activity of rituximab in vivo","volume":"140","author":"Reddy","year":"2008","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2018.12.020_bb0070","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.046","article-title":"Thrombocytopenia in patients with myelodysplastic syndromes: still an unsolved problem","volume":"10","author":"Basood","year":"2018","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"10.1016\/j.intimp.2018.12.020_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/2040620718775629","article-title":"Update on the role of lenalidomide in patients with multiple myeloma","volume":"9","author":"Holstein","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.intimp.2018.12.020_bb0080","article-title":"Amphotericin B, an anti-fungal medication, directly increases the cytotoxicity of NK cells","volume":"18","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2018.12.020_bb0085","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0090","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.immuni.2010.02.004","article-title":"Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase","volume":"32","author":"Kim","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2018.12.020_bb0095","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"Parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.intimp.2018.12.020_bb0100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1084\/jem.20051143","article-title":"Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells","volume":"202","author":"Bryceson","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.12.020_bb0105","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11686","article-title":"Stepwise phosphorylation of p65 promotes NF-kappaB activation and NK cell responses during target cell recognition","volume":"7","author":"Kwon","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2018.12.020_bb0110","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/eji.201040444","article-title":"IQGAP1 involvement in MTOC and granule polarization in NK-cell cytotoxicity","volume":"41","author":"Kanwar","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2018.12.020_bb0115","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.20132038","article-title":"EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase Cgamma, Ca++, and Erk, leading to granule polarization","volume":"211","author":"Perez-Quintero","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2018.12.020_bb0120","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000026555","article-title":"Antidepressants augment natural killer cell activity: in vivo and in vitro","volume":"39","author":"Frank","year":"1999","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.intimp.2018.12.020_bb0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pathophys.2006.09.003","article-title":"CD26\/DPPIV expression and 8-azaguanine response in T-acute lymphoblastic leukaemia cell lines in culture","volume":"14","author":"Dourado","year":"2007","journal-title":"Pathophysiology"},{"key":"10.1016\/j.intimp.2018.12.020_bb0130","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1182\/blood-2013-10-536078","article-title":"Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia","volume":"123","author":"Herrmann","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2018.12.020_bb0135","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.leukres.2016.06.002","article-title":"The prognostic significance of surface dipeptidylpeptidase IV (CD26) expression in B-cell chronic lymphocytic leukemia","volume":"47","author":"Matuszak","year":"2016","journal-title":"Leuk. Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0140","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajh.23404","article-title":"Acute myeloid leukemia: 2013 update on risk-stratification and management","volume":"88","author":"Estey","year":"2013","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.intimp.2018.12.020_bb0145","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ijc.25635","article-title":"Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation","volume":"128","author":"Schmiedel","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.intimp.2018.12.020_bb0150","first-page":"2771","article-title":"The combination of Flavokawain B and Daunorubicin induces apoptosis in human myeloid leukemic cells by modifying NF-kappaB","volume":"38","author":"Lee","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0155","doi-asserted-by":"crossref","first-page":"e311","DOI":"10.1038\/emm.2017.42","article-title":"Molecular checkpoints controlling natural killer cell activation and their modulation for cancer immunotherapy","volume":"49","author":"Kwon","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2018.12.020_bb0160","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-07-4405","article-title":"Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells","volume":"14","author":"Wu","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2018.12.020_bb0165","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/2040620716652861","article-title":"A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma","volume":"7","author":"Arora","year":"2016","journal-title":"Ther. Adv. Hematol."},{"key":"10.1016\/j.intimp.2018.12.020_bb0170","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1182\/blood-2011-06-360255","article-title":"IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect","volume":"118","author":"Benson","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2018.12.020_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1182\/blood-2015-01-625004","article-title":"Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds","volume":"126","author":"Lagrue","year":"2015","journal-title":"Blood"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918309834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576918309834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:11:47Z","timestamp":1761585107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576918309834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":35,"alternative-id":["S1567576918309834"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.020","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct potentiation of NK cell cytotoxicity by 8-azaguanine with potential antineoplastic activity","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2018.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}